NKGen Biotech - Snk02 Appears to Have Some Clinical Activity Against Pretreated Solid Tumors Despite Lack of Lymphodepletion
NKGen生物技術-Snk02似乎對經過預處理的固體腫瘤具有一定的臨床活性,儘管缺乏淋巴清除。
NKGen Biotech - Snk02 Appears to Have Some Clinical Activity Against Pretreated Solid Tumors Despite Lack of Lymphodepletion
NKGen生物技術-Snk02似乎對經過預處理的固體腫瘤具有一定的臨床活性,儘管缺乏淋巴清除。
譯文內容由第三人軟體翻譯。